The U.S. Court of International Trade issued a published opinion in a case brought by Chinese biotech firm Neimenggu Fufeng Biotechnologies Co. against the United States, likely contesting antidumping or countervailing duty determinations. The outcome affects duty rates or methodology applicable to Chinese biotechnology/fermentation product exports to the U.S.

Daily Signals alert

Get relevant trade-policy alerts in Daily Trade Signals.

Subscription scopeDaily Trade SignalsThe daily email, with this source context saved for matching.Only AD/CVDFilter future fragments toward this policy instrument.This HS code or caseFollow changes linked to HS 29.

Subscribes you to Daily Trade Signals and stores this source page, selected scope, and a timestamp for alert matching. Unsubscribe anytime. See our privacy policy.

Review Snapshot

Scope: HS 29, 35 / CN, US / AD/CVD
Question: Does this source change alter exposure, timing, or review priority for HS 29, 35 / CN, US / AD/CVD?
Next move: Check HS 29 in Tariffs, then save the scope if this question repeats.

Legal / Policy Context

Policy instruments

AD/CVD

Practical Takeaways

Check the tagged HS codes in tariff context before treating this as a general market signal.
Use Paths to see adjacent source records, countries, and instruments before escalating this as a standalone change.

Source Trail

CourtListenerPrimary briefing source

Open source